Literature DB >> 12958244

Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae and molecular characterization of multidrug-resistant serotype 19F, 6B, and 23F Pneumococci in northern Thailand.

Hiroshi Watanabe1, Norichika Asoh, Kazuhiko Hoshino, Kiwao Watanabe, Kazunori Oishi, Weerayut Kositsakulchai, Tippaya Sanchai, Khemrassamee Kunsuikmengrai, Sumpun Kahintapong, Banyong Khantawa, Prasit Tharavichitkul, Thira Sirisanthana, Tsuyoshi Nagatake.   

Abstract

Penicillin-resistant Streptococcus pneumoniae is widely spread worldwide. Our study was undertaken to examine the susceptibility and serotypes of S. pneumoniae in northern Thailand. Ninety-three S. pneumoniae strains were isolated from 93 patients at Chiang Mai University Hospital, Chiang Mai, Thailand, from September 1999 to June 2000. The strains were isolated from sputum (n = 51), blood (n = 15), nasopharynges (n = 14), and other sources (e.g., pus, ears, ascites, and cerebrospinal fluid) (n = 13). Of the 93 isolates, 29 (31.2%) were susceptible, 24 (25.8%) showed intermediate resistance (MIC, 0.12 to 1.0 micro g/ml), and 40 (43.0%) were fully resistant (MIC, >/=2.0 micro g/ml) to penicillin G. Seven (46.7%) from blood, 5 (35.7%) from nasopharynges, 15 (29.4%) from sputum, and 2 (15.4%) from other sources were susceptible isolates. Serotyping with the use of antiserum revealed differences in the predominant types that were susceptible (6A, 11A, and 19A), intermediately resistant (6B and 23F), and fully resistant (6B, 19F, and 23F). Molecular typing by pulsed-field gel electrophoresis of multidrug-resistant pneumococci showed four patterns (A, B, C, and D) for 16 isolates of serotype 19F, with pattern B being predominant (12 isolates). This finding was different from that with the Taiwan multidrug-resistant serotype 19F clone. Eleven isolates of serotype 6B all showed pattern E, and nine isolates of serotype 23F showed two patterns (F and G), with pattern F being predominant (seven isolates). This finding was similar to that with the Spanish multidrug-resistant serotype 23F clone. Our results indicated that the resistance of pneumococci to antibiotics in northern Thailand is progressing rapidly and that effort should be intensified to prevent any spread of pandemic multidrug-resistant serotypes 19F, 6B, and 23F.

Entities:  

Mesh:

Year:  2003        PMID: 12958244      PMCID: PMC193840          DOI: 10.1128/JCM.41.9.4178-4183.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

2.  Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center.

Authors:  H Yano; M Suetake; A Kuga; K Irinoda; R Okamoto; T Kobayashi; M Inoue
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.

Authors:  M H Kyaw; I G Jones; H Campbell
Journal:  Acta Paediatr       Date:  2001-05       Impact factor: 2.299

4.  Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994--1998: regional variation and temporal trends.

Authors:  S Chariyalertsak; T Sirisanthana; O Saengwonloey; K E Nelson
Journal:  Clin Infect Dis       Date:  2001-03-07       Impact factor: 9.079

5.  A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia.

Authors:  P Phanuphak; M L Grayson; S Sirivichayakul; S Suwanagool; K Ruxrungtham; M Hanvanich; W Ratanasuwan; S Ubolyam; M D Hughes; C A Wanke; S M Hammer
Journal:  Aust N Z J Med       Date:  2000-02

6.  23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial.

Authors:  N French; J Nakiyingi; L M Carpenter; E Lugada; C Watera; K Moi; M Moore; D Antvelink; D Mulder; E N Janoff; J Whitworth; C F Gilks
Journal:  Lancet       Date:  2000-06-17       Impact factor: 79.321

Review 7.  Human immunodeficiency virus and respiratory infection.

Authors:  E A Ashley; M A Johnson; M C Lipman
Journal:  Curr Opin Pulm Med       Date:  2000-05       Impact factor: 3.155

Review 8.  Pneumococcal conjugate vaccine for young children.

Authors:  R K Zimmerman
Journal:  Am Fam Physician       Date:  2001-05-15       Impact factor: 3.292

9.  Pneumonia in HIV-infected patients: a case-control survey of factors involved in risk and prevention.

Authors:  M Guerrero; S Kruger; A Saitoh; F Sorvillo; K J Cheng; C French; G Beall
Journal:  AIDS       Date:  1999-10-01       Impact factor: 4.177

10.  Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis.

Authors:  Adela G de la Campa; María-José Ferrandiz; Fe Tubau; Román Pallarés; Federico Manresa; Josefina Liñares
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more
  2 in total

1.  Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan.

Authors:  L Qin; H Watanabe; H Yoshimine; H Guio; K Watanabe; K Kawakami; A Iwagaki; H Nagai; H Goto; T Kuriyama; Y Fukuchi; T Matsushima; S Kudoh; K Shimada; K Matsumoto; T Nagatake; T Mizota; K Oishi
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

2.  Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid.

Authors:  Catrin E Moore; Amphone Sengduangphachanh; Thaksinaporn Thaojaikong; Joy Sirisouk; Dona Foster; Rattanaphone Phetsouvanh; Lesley McGee; Derrick W Crook; Paul N Newton; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.